2025/01/23 AD
Findings related to discrepancies with approved dossier and fake record
PMDA ORANGE LETTER_2024.10
2025/05/15 AD
Deficiencies in multi-purpose manufacturing site
PMDA ORANGE LETTER_2025.01
AD
医薬品製造所に対する査察の各規制当局動向
Lily Yu
医薬品の技術移転のポイント【第3回】
GMP Platform
Atsushi Nunome
You will be navigated to the CM Plus company website.
CM Plus Group Website